This is a recent incident biospace The article is titled “How effective will TrumpRx and other direct-to-consumer drug pricing initiatives be?” A is quoted in the article as:
Whereas [direct-to-consumer] DTC has been a growing trend in biopharma for about two years – Lilly launched LillyDirect in January 2024 – with the number of drugmakers selling their products directly to patients increasing in recent months.
Drug pricing is a delicate issue and pharmaceutical companies have long been under pressure to improve access to medicines. “The goal of setting drug prices is to set them high enough to encourage drug companies to finance the research and development needed to bring new drugs to market,” said Jason Shafrin, senior managing director of the Center for Healthcare Economics and Policy at FTI Consulting. biospace In an email.
On the other hand, drugs should be priced “so that the benefits to society outweigh the costs,” he said.
On both cases, Shafrin spoke with other experts biospace For this piece, the effectiveness of the DTC approach was questioned.
You can read the full article here.
